Sparano JA - Search Results

1

Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer.

Sparano JA, Crager MR, Tang G, Gray RJ, Stemmer SM, Shak S. Sparano JA, et al. J Clin Oncol. 2021 Feb 20;39(6):557-564. doi: 10.1200/JCO.20.03007. Epub 2020 Dec 11. J Clin Oncol. 2021. PMID: 33306425 Free PMC article.

2

Phase I trial of low-dose, prolonged continuous infusion fluorouracil plus interferon-alfa: evidence for enhanced fluorouracil toxicity without pharmacokinetic perturbation.

Sparano JA, Wadler S, Diasio RB, Zhang R, Lu Z, Schwartz EL, Einzig A, Wiernik PH. Sparano JA, et al. J Clin Oncol. 1993 Aug;11(8):1609-17. doi: 10.1200/JCO.1993.11.8.1609. J Clin Oncol. 1993. PMID: 8336197 Clinical Trial.

3

Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma.

Sparano JA, Robert N, Silverman P, Lazarus H, Malik U, Venkatraj U, Sarta C. Sparano JA, et al. J Clin Oncol. 1996 Sep;14(9):2576-83. doi: 10.1200/JCO.1996.14.9.2576. J Clin Oncol. 1996. PMID: 8823338 Clinical Trial.

4

Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study.

Sparano JA, Neuberg D, Glick JH, Robert NJ, Goldstein LJ, Sledge GW, Wood W. Sparano JA, et al. J Clin Oncol. 1997 May;15(5):1880-4. doi: 10.1200/JCO.1997.15.5.1880. J Clin Oncol. 1997. PMID: 9164198 Clinical Trial.

5

Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer.

Sparano JA, Speyer J, Gradishar WJ, Liebes L, Sridhara R, Mendoza S, Fry D, Egorin MJ. Sparano JA, et al. J Clin Oncol. 1999 Mar;17(3):880-6. doi: 10.1200/JCO.1999.17.3.880. J Clin Oncol. 1999. PMID: 10071279 Clinical Trial.

6

Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study.

Sparano JA, Hu P, Rao RM, Falkson CI, Wolff AC, Wood WC. Sparano JA, et al. J Clin Oncol. 1999 Dec;17(12):3828-34. doi: 10.1200/JCO.1999.17.12.3828. J Clin Oncol. 1999. PMID: 10577856 Clinical Trial.

7

Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196.

Sparano JA, O'Neill A, Schaefer PL, Falkson CI, Wood WC. Sparano JA, et al. J Clin Oncol. 2000 Jun;18(12):2369-77. doi: 10.1200/JCO.2000.18.12.2369. J Clin Oncol. 2000. PMID: 10856096 Clinical Trial.

8

Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer.

Sparano JA, Malik U, Rajdev L, Sarta C, Hopkins U, Wolff AC. Sparano JA, et al. J Clin Oncol. 2001 Jun 15;19(12):3117-25. doi: 10.1200/JCO.2001.19.12.3117. J Clin Oncol. 2001. PMID: 11408509 Clinical Trial.

9

Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.

Kalfon B, Fineberg S, Gu Y, Anand K, Dalal A, Jones J, Sparano JA. Kalfon B, et al. Among authors: sparano ja. Clin Breast Cancer. 2001 Apr;2(1):67-72. doi: 10.3816/CBC.2001.n.013. Clin Breast Cancer. 2001. PMID: 11899385

10

Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphoma.

Salman H, Perez A, Sparano JA, Ratech H, Negassa A, Hopkins U, Villani G, Fuks J, Wiernik PH. Salman H, et al. Among authors: sparano ja. Am J Clin Oncol. 2003 Aug;26(4):338-43. doi: 10.1097/01.COC.0000020651.11284.DE. Am J Clin Oncol. 2003. PMID: 12902881 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters